-
srdr.ahrq.gov/projects/1671/studies/196181
January 01, 2010 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196161
January 01, 1994 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196151
January 01, 2011 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196164
January 01, 1997 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196171
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196177
January 01, 2009 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196174
January 01, 2014 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196183
January 01, 1995 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196179
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196391
January 01, 2012 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196197
January 01, 2005 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196390
January 01, 2012 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196396
January 01, 2012 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196400
January 01, 2013 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196202
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196389
January 01, 2007 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196195
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196204
January 01, 1994 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196388
January 01, 2014 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196196
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?